marimastat has been researched along with Cell Transformation, Neoplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dharmasivam, M; Park, KC; Richardson, DR | 1 |
| Charvat, S; Chignol, MC; Le Griel, C; Schmitt, D; Serres, M | 1 |
1 review(s) available for marimastat and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
The Role of Extracellular Proteases in Tumor Progression and the Development of Innovative Metal Ion Chelators that Inhibit their Activity.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Transformation, Neoplastic; Chelating Agents; Disease Progression; Drug Design; Drug Screening Assays, Antitumor; Extracellular Fluid; Extracellular Vesicles; Humans; Hydroxamic Acids; Iron; Iron Chelating Agents; Kallikreins; Matrix Metalloproteinases; Molecular Targeted Therapy; Neoplasm Proteins; Oxaprozin; Peptide Hydrolases; Phenylalanine; Protease Inhibitors; Protein Kinases; Pyridines; Thiophenes; Thiosemicarbazones; Zinc | 2020 |
1 other study(ies) available for marimastat and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Ras-transfection up-regulated HaCaT cell migration: inhibition by Marimastat.
Topics: Cell Adhesion; Cell Line, Transformed; Cell Movement; Cell Transformation, Neoplastic; Cells, Cultured; Clone Cells; Collagen; Dose-Response Relationship, Drug; Enzyme Inhibitors; Genes, ras; Humans; Hydroxamic Acids; Integrin alpha3beta1; Integrins; Keratinocytes; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Receptors, Collagen; Tissue Inhibitor of Metalloproteinase-2; Transfection; Up-Regulation | 1999 |